Literature DB >> 17977584

Restless legs syndrome: a common disorder in patients with rheumatologic conditions.

Wayne A Hening1, Christine K Caivano.   

Abstract

OBJECTIVES: To review the symptoms, differential diagnosis, and treatment of the restless legs syndrome (RLS), and its relevance within rheumatologic practice.
METHODS: Review of the scientific literature on RLS to summarize symptom presentation, burden, diagnosis, treatment, and association with rheumatologic conditions.
RESULTS: RLS is a sensorimotor neurological disorder characterized by an irresistible urge to move the legs, usually accompanied or caused by unpleasant sensations within the legs. These sensations are sometimes described as achy or painful. They may cause sleep disruption and impair quality of life. RLS may be primary, of unknown etiology, with a likely genetic basis, or secondary, provoked by other conditions. Secondary RLS often improves when the underlying condition is treated or resolves. Since RLS is common in rheumatologic disorders such as rheumatoid arthritis or Sjögren's syndrome, rheumatologists need to be familiar with the condition. Primary care physicians may misattribute RLS symptoms to other conditions and refer patients to specialists for treatment. Since RLS symptoms can be similar to, and mistaken for, symptoms in rheumatologic diseases, patients may be referred to rheumatologists. Therefore, it is important that rheumatologists be able to recognize, differentiate, diagnose, and treat RLS.
CONCLUSIONS: The clinical diagnosis of RLS is based on 4 essential diagnostic criteria related to the urge to move that characterizes this disorder. Beyond good sleep hygiene and behavioral measures, dopaminergic agents are first-line treatments for primary RLS. Anticonvulsants, opioids, and sedative/hypnotics may also have a role in management.

Entities:  

Mesh:

Year:  2007        PMID: 17977584     DOI: 10.1016/j.semarthrit.2007.09.001

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  9 in total

Review 1.  Update in restless legs syndrome.

Authors:  Rachel E Salas; Charlene E Gamaldo; Richard P Allen
Journal:  Curr Opin Neurol       Date:  2010-08       Impact factor: 5.710

Review 2.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

Review 3.  Restless legs syndrome: differential diagnosis and management with pramipexole.

Authors:  Francesca Brindani; Francesca Vitetta; Franco Gemignani
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

4.  Crohn's disease is associated with restless legs syndrome.

Authors:  Leonard B Weinstock; Brian P Bosworth; Ellen J Scherl; Ellen Li; Ugonna Iroku; Melissa A Munsell; Gerard E Mullin; Gerald E Mullen; Arthur S Walters
Journal:  Inflamm Bowel Dis       Date:  2010-02       Impact factor: 5.325

5.  Severity and frequency of restless legs syndrome in patients with familial Mediterranean fever.

Authors:  Samet Yılmaz; Burhanettin Çiğdem; Şeyda Figül Gökçe; Sevil Ceyhan-Doğan; Hatice Balaban
Journal:  J Int Med Res       Date:  2017-06-12       Impact factor: 1.671

Review 6.  Restless Legs Syndrome: From Pathophysiology to Clinical Diagnosis and Management.

Authors:  Shiyi Guo; Jinsha Huang; Haiyang Jiang; Chao Han; Jie Li; Xiaoyun Xu; Guoxin Zhang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Front Aging Neurosci       Date:  2017-06-02       Impact factor: 5.750

7.  Experience of sleep disruption in primary Sjögren's syndrome: A focus group study.

Authors:  Katie L Hackett; Vincent Deary; Katherine Ho Deane; Julia L Newton; Wan-Fai Ng; Tim Rapley
Journal:  Br J Occup Ther       Date:  2018-01-11       Impact factor: 1.243

8.  Dopamine induces in vitro migration of synovial fibroblast from patients with rheumatoid arthritis.

Authors:  Lina van Nie; Laura Salinas-Tejedor; Nicole Dychus; Frank Fasbender; Marie-Lisa Hülser; Maurizio Cutolo; Stefan Rehart; Elena Neumann; Ulf Müller-Ladner; Silvia Capellino
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

Review 9.  Dopaminergic Agents in Rheumatoid Arthritis.

Authors:  Silvia Capellino
Journal:  J Neuroimmune Pharmacol       Date:  2019-04-23       Impact factor: 4.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.